Rockaway, NJ – LinkSPINE, a company focused upon simple, less invasive implants and techniques for spinal surgery is pleased to announce the first US implantation of the FacetLINK MINI. The MINI uses two screws and an expandable cross-connector assembly to stabilize the lumbar spine following a tissue-sparing midline decompression.
Dhruv Pateder, MD, an Orthopedic Spinal Surgeon, performed the first US MINI case at HCA Reston Hospital Center in Reston, VA. Dr. Pateder comments, “Using a minimally invasive technique, FacetLINK MINI allows rigid posterior spinal column fixation with only two cross-linked lag screws instead of a traditional, open pedicle screw and rod construct where four screws are needed. The FacetLINK MINI device is quickly and efficiently placed utilizing a very intuitive surgical technique. The patient is doing great and was discharged the next day.”
Massimo Calafiore, President of LinkSPINE states, “FacetLINK MINI fits within the bounds of a midline decompression exposure, requiring no additional dissection beyond what was planned for the decompression itself. This is based upon the medial to lateral screw trajectories which anchor the devices to the bone, and the need for just two screws to complete a one level construct.”
Dennis Farrell, VP of Marketing and Product Development adds, “the early clinical experience in the EU has been very encouraging, with 80 cases performed over the past 30 months. We are excited to build upon this experience here in the US as we continue to work towards the possibility of improving patient outcomes through simple, less invasive surgical techniques.”
FacetLINK MINI is manufactured from titanium and is designed for placement in the setting of a bilateral decompression through bilateral laminotomies. It is anchored with Trans-articular Pedicle Screws that cross the facets, pin the joints, and terminate at the base of the pedicle. An adjustable monorail rigidly connects the screws for additional stability.
The Facet-Link Stabilization Platform is intended to stabilize the spine as an aid to fusion through immobilization of the facet joints. The system is indicated for use with bone graft, at single or multiple levels, from L3 to S1 (inclusive). The Platform is indicated for the treatment of any or all of the following:
2. Degenerative disc disease (DDD) as defined as back pain of discogenic origin as confirmed by radiographic studies.
3. Degeneration of the facets with instability.